Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“Fantastic 1st day of the American Society of Clinical Oncology (ASCO) Quality Care Symposium. Ensuring that all patients have access to quality cancer care and life saving therapeutics – including but not limited to clinical trials – is essential!
Always good to break this down and develop new ideas with ASCO’s visionary leader, Dr Clifford Hudis.”
More posts featuring Karen Knudsen.